Kuros Biosciences AG/ CH0325814116 /
| 2024-11-15 5:18:12 PM | Chg. -6.50 | Volume | Bid5:20:00 PM | Ask5:20:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 25.00CHF | -20.63% | 19,018 Turnover: 491,952.55 |
-Bid Size: - | -Ask Size: - | 912.21 mill.CHF | - | - |
Assets
|
2010 IFRS in mill. CHF |
2011 IFRS in mill. CHF |
2012 IFRS in mill. CHF |
2013 IFRS in mill. CHF |
2014 IFRS in mill. CHF |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 4 | .1000 | .1000 | .1000 | 0.0000 | ||||||
| Intangible Assets | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Long-Term Investments | .1000 | .1000 | .1000 | .1000 | .1000 | ||||||
| Fixed Assets | 4 | .2000 | .2000 | .2000 | .1000 | ||||||
| Inventories | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Accounts Receivable | - | - | - | - | - | ||||||
| Cash and Cash Equivalents | 33.8000 | 24.5000 | 28.6000 | 39.8000 | 16.9000 | ||||||
| Current Assets | 50 | 30.6000 | 30.2000 | 40.3000 | 17.6000 | ||||||
| Total Assets | 54.1000 | 30.8000 | 30.4000 | 40.5000 | 17.6000 | ||||||
Liabilities
|
2010 IFRS in mill. CHF |
2011 IFRS in mill. CHF |
2012 IFRS in mill. CHF |
2013 IFRS in mill. CHF |
2014 IFRS in mill. CHF |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | .5000 | .3000 | .4000 | 1.5000 | .2000 | ||||||
| Long-term debt | 39 | - | 13.9000 | 27.5000 | - | ||||||
| Liabilities to Banks | 39 | 35.7000 | 13.9000 | 27.5000 | 42.5000 | ||||||
| Provisions | 5.1000 | 2.3000 | 2.3000 | 2.5000 | .4000 | ||||||
| Liabilities | 47.5000 | 42.5000 | 20.4000 | 36.3000 | 43.9000 | ||||||
| Share Capital | .5000 | .5000 | 2.2000 | 3.1000 | 3.1000 | ||||||
| Total Equity | 6.6000 | -11.7000 | 10 | 4.2000 | -26.2000 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 54.1000 | 30.8000 | 30.4000 | 40.5000 | 17.6000 | ||||||
Income Statement
|
2010 IFRS in mill. CHF |
2011 IFRS in mill. CHF |
2012 IFRS in mill. CHF |
2013 IFRS in mill. CHF |
2014 IFRS in mill. CHF |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 22.3000 | 1.6000 | 1.1000 | 1 | 1 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -3.9000 | -19.7000 | -13.5000 | -23.3000 | -19.9000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | -1.5000 | -18.8000 | -10.1000 | -30.8000 | -34 | ||||||
| Income Taxes | 0.0000 | 0.0000 | .9000 | 0.0000 | 0.0000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -1.5000 | -18.8000 | -9.2000 | -30.8000 | -34 | ||||||
Per Share
Cash Flow
|
2010 IFRS in mill. CHF |
2011 IFRS in mill. CHF |
2012 IFRS in mill. CHF |
2013 IFRS in mill. CHF |
2014 IFRS in mill. CHF |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -4.7000 | -8.8000 | -11.5000 | -19.2000 | -23.8000 | ||||||
| Cash Flow from Investing Activities | 29.1000 | 3.9000 | 4 | .1000 | .6000 | ||||||
| Cash Flow from Financing | -11.3000 | -4 | 11.6000 | 30.1000 | .2000 | ||||||
| Decrease / Increase in Cash | 13.2000 | -8.9000 | 4.1000 | 11.1000 | -23 | ||||||
| Employees | - | - | - | - | - | ||||||
